Cargando…
The immunomodulatory quinoline-3-carboxamide paquinimod reverses established fibrosis in a novel mouse model for liver fibrosis
Quinoline-3-carboxamides (Q substances) are small molecule compounds with anti-inflammatory properties. In this study, we used one of these substances, Paquinimod, to treat a novel model for chronic liver inflammation and liver fibrosis, the NOD-Inflammation Fibrosis (N-IF) mouse. We show that treat...
Autores principales: | Fransén Pettersson, Nina, Deronic, Adnan, Nilsson, Julia, Hannibal, Tine D., Hansen, Lisbeth, Schmidt-Christensen, Anja, Ivars, Fredrik, Holmberg, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124744/ https://www.ncbi.nlm.nih.gov/pubmed/30183741 http://dx.doi.org/10.1371/journal.pone.0203228 |
Ejemplares similares
-
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016) -
A New Mouse Model That Spontaneously Develops Chronic Liver Inflammation and Fibrosis
por: Fransén-Pettersson, Nina, et al.
Publicado: (2016) -
Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth
por: Deronic, Adnan, et al.
Publicado: (2016) -
Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
por: Tahvili, Sahar, et al.
Publicado: (2018) -
Deficiency in plasmacytoid dendritic cells and type I interferon signalling prevents diet-induced obesity and insulin resistance in mice
por: Hannibal, Tine D., et al.
Publicado: (2017)